CMV glycoproteins and recombinant vectors

Details for Australian Patent Application No. 2011230619 (hide)

Owner Oregon Health & Science University

Inventors Picker, Louis; Frueh, Klaus; Hansen, Scott G.; Powers, Colin

Agent FB Rice

Pub. Number AU-A-2011230619

PCT Pub. Number WO2011/119920

Priority 61/317,647 25.03.10 US

Filing date 25 March 2011

Wipo publication date 29 September 2011

International Classifications

C12N 15/38 Mutation or genetic engineering

A61K 39/245 Medicinal preparations containing antigens or antibodies - Herpetoviridae, e.g. herpes simplex virus

C12N 15/86 Mutation or genetic engineering - Viral vectors

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/119920 Priority application(s): WO2011/119920

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011230632-Impedance mediated control of power delivery for electrosurgery

2011230618-Adenosine compounds and their use thereof